Polyrizon Ltd. (PLRZ)
NASDAQ: PLRZ
· Real-Time Price · USD
0.77
-0.37 (-32.46%)
At close: May 06, 2025, 3:59 PM
0.71
-8.20%
Pre-market: May 07, 2025, 04:08 AM EDT
-32.46% (1D)
| Bid | 0.63 |
| Market Cap | 2.99M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.5 |
| PE Ratio (ttm) | -1.54 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.71 |
| Volume | 4,123,262 |
| Avg. Volume (20D) | 7,087,116 |
| Open | 1.05 |
| Previous Close | 1.14 |
| Day's Range | 0.67 - 1.13 |
| 52-Week Range | 0.25 - 4.80 |
| Beta | -3.68 |
About PLRZ
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel....
Industry Biotechnology
Sector Healthcare
IPO Date Oct 29, 2024
Employees 2
Stock Exchange NASDAQ
Ticker Symbol PLRZ
3 days ago
+298.58%
Polyrizon shares are trading higher after the comp...
Unlock content with
Pro Subscription
1 month ago
-22.93%
Polyrizon shares are trading lower after the company announced a $17 million private placement.